BHRT vs traditional HRT: which should I ask for and where?

Short answer

• If you want the strongest evidence for safety, quality and known dosing, ask your clinician about FDA‑approved (traditional) HRT first — e.g., transdermal estradiol patches (Vivelle‑Dot, Climara), oral estradiol (Estrace), low‑dose vaginal estrogen (Estring, Vagifem) and micronized progesterone (Prometrium).
• If you want a customized formulation and are willing to accept less regulatory oversight and less rigorous safety data, ask about compounded “bioidentical” hormone therapy (BHRT) — but only from an experienced menopause clinician working with an accredited compounding pharmacy and with careful monitoring.

Why (short)

• Traditional HRT: standardized dosing, FDA manufacturing and safety data, large trials and guideline recommendations.
• BHRT: may be tailored (dose/route/combination) and marketed as “natural,” but clinical evidence of superiority is lacking and formulations are not FDA‑approved or uniformly regulated.

What to ask your clinician (things to say or bring up)

• Describe your symptoms, goals and medical history (breast cancer history, blood clotting, heart disease, stroke, migraines, smoking).
• Ask: “What are the proven benefits and risks of the hormone options for someone with my medical history?”
• Ask about routes and why one is preferred (e.g., transdermal estradiol may have lower clot risk than oral).
• If a clinician recommends BHRT, ask which lab tests they’ll use (avoid relying only on saliva tests), how dose is determined, which compounding pharmacy they use, how quality/consistency is verified, and what follow‑up and safety monitoring they’ll do.
• Ask about non‑hormonal alternatives and about vaginal (local) vs systemic therapy for genitourinary symptoms.

Where to go / who to see (specific places and why)

• Primary options for evidence‑based care:
  • Your gynecologist or primary care physician — many manage menopause/HRT.
  • Menopause specialists: use the North American Menopause Society (NAMS) “Find a Menopause Practitioner” to locate clinicians with menopause expertise. NAMS‑trained clinicians follow current guideline recommendations.
  • Major centers with menopause programs: Mayo Clinic, Cleveland Clinic Center for Menopause, Johns Hopkins Women’s Health — these centers have multidisciplinary teams and up‑to‑date protocols.
• If you prefer BHRT/compounded hormones:
  • Use a clinician experienced in menopause who understands the limits of the evidence and who uses appropriate testing and monitoring. Ask them to work with an accredited compounding pharmacy.
  • Look for compounding pharmacies accredited by the Pharmacy Compounding Accreditation Board (PCAB) or URAC. Examples often used nationally (check current accreditation first): Wedgewood Pharmacy (Wedgewood Compounding), Empower Pharmacy, Fagron. Don’t pick a pharmacy just because it advertises “bioidentical” — verify accreditation and sterility/quality checks.
• For telehealth/concierge options:
  • Some reputable telemedicine services and menopause clinics now provide HRT (traditional or compounded) with remote follow‑up — check credentials and ask about lab monitoring and local lab partnerships. Examples: Evexia (clinic networks vary), Maven Clinic (women’s health telehealth), or established academic centers that offer virtual consults. Verify the provider’s board certification and menopause training.

Practical tips and safety checks

• Prefer FDA‑approved products when possible for systemic therapy; use low‑dose vaginal estrogen for local symptoms.
• If you have risk factors for blood clots, cardiovascular disease, or breast cancer, discuss alternatives and risk mitigation (route selection, lowest effective dose, duration).
• Avoid clinicians who base dosing solely on saliva hormone tests — these are not recommended for systemic HRT dosing. Blood tests and symptom response plus guideline‑driven risk assessment are standard.
• Get baseline screening as indicated (mammogram, blood pressure, lipids, glucose/HbA1c, liver tests, pregnancy test if relevant) and schedule regular follow‑up visits after starting therapy.

Bottom line Start the conversation with a clinician experienced in menopause: ask first about evidence‑based, FDA‑approved HRT options and whether those meet your goals and risk profile. If you still prefer BHRT for specific reasons, insist on an evidence‑minded prescriber, accredited compounding pharmacy, clear monitoring plan, and informed consent about the limits of safety data.

If you want, tell me your age, symptoms and major medical history (e.g., prior breast cancer, clotting disorder, heart disease, smoking) and I can suggest more targeted questions and which specific products/routes are most likely to be recommended.